Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Newsbot!
    Banned
    • Feb 2008
    • 1331

    PubMed: YOABS: Yet Other Aligner of Biological Sequences -- an efficient linearly sca

    Syndicated from PubMed RSS Feeds

    YOABS: Yet Other Aligner of Biological Sequences -- an efficient linearly scaling nucleotide aligner.

    Bioinformatics. 2012 Mar 7;

    Authors: Galinsky V

    Abstract
    MOTIVATION: Explosive growth of short read sequencing technologies in the recent years resulted in rapid development of many new alignment algorithms and programs. But most of them are not efficient or not applicable for reads ? 200 bp because these algorithms specifically designed to process short queries with relatively low sequencing error rates. However the current trend to increase reliability of detection of structural variations in assembled genomes as well as to facilitate de novo sequencing demand complimenting high-throughput short read platforms with long-read mapping. Thus, algorithms and programs for efficient mapping of longer reads are becoming crucial. However, the choice of long read aligners effective in terms of both performance and memory are limited and includes only handful of hash table (BLAT, SSAHA2) or trie (BWT-SW, BWA-SW) based algorithms. RESULTS: New O(n) algorithm that combines the advantages of both hash and trie based methods has been designed to effectively align long biological sequences (? 200 bp) against a large sequence database with small memory footprint (e.g. ~ 2 GB for the human genome). The algorithm is accurate and significantly more fast than BLAT or BWT-SW, but similar to BWT-SW it can find all local alignments. It is as accurate as SSAHA2 or BWA-SW, but uses 3+ times less memory and 10+ times faster than SSAHA2, several times faster than BWA-SW with low error rates and almost two times less memory. AVAILABILITY: The local hit table binary and indices are available at ftp://styx.ucsd.edu. CONTACT: [email protected].


    PMID: 22402614 [PubMed - as supplied by publisher]



    More...

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...